Companies showcasing equipment and services at the event include Shilpa Biologicals (Booth 12J33), which is announcing the ...

The deal also gives Novartis exclusive options to license additional next-generation programs built on Abogen's proprietary ...

Manufacturers are encouraged to treat resiliency policy as an actionable trend and proactively shape solutions rather than ...

In US regulatory news, the FDA opened applications for its Expedited IND Pilot on September 15. 1 The program pairs drug ...

Machine-readable digital standards integrated into LIMS, ELNs, and regulatory platforms reduce transcription risk, streamline ...

In June 1937, a salesman for the S. E. Massengill Company reported demand in the southern states for sulfanilamide in liquid ...

Scarboro contends these findings should be treated as design information rather than as a sign that patients need more ...

Access Part 1 of this interview, in which Piervincenzi explains how benchmarking could reward reliable generic drug suppliers ...

The FDA has approved AbbVie's JUVMO (tavapadon), as the first and only selective D1/D5 receptor agonist for adults with ...

Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps. When Merck and Moderna's INTerpath-001 trial of ...

This article evaluates a structured, risk-based framework for the development, execution, and life cycle governance of master production and control records and batch production and control records ...

In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol ...